GLP-1’s Drove Eli Lilly’s Record-Breaking Q2, but AI Will Be Its Future - 24/7 Wall St.

A major pharmaceutical company sees AI as central to its future business strategy, beyond its current blockbuster drugs. This matters because it suggests AI will reshape pharmaceutical development and healthcare innovation.